semaglutide original use FDA Approval vs Compounded Alternatives Zydus Rolls Out Semaglutide Injection

10.1042/BJ20101610 Biochem

7.3.3 Safety and specificity concerns Long-term safety assessment remains paramount, particularly regarding the theoretical risk of impairing tumor surveillance by chronically inhibiting a controlled cell death pathway, potential off-target effects of RNA-based therapies, and the challenge of achieving cell-type specificity without affecting essential ferroptosis functions in other tissues

Immunohistochemistry reveals positivity for cytokeratins, epithelial membrane antigen (EMA), vimentin, and monoclonal antibody to melanosome (HMB-45) in the larger cells, and negativity for S-100 protein

The results showed inconsistencies in what was in each sample